5th Jul 2005 07:00
Dechra Pharmaceuticals PLC05 July 2005 Issued by Citigate Dewe Rogerson Ltd, BirminghamDate: Tuesday, 5 July 2005 Embargoed: 7.00am Dechra Pharmaceuticals PLC issues the following pre-closed period update aheadof publication of the Group's preliminary results for the year ended 30 June2005 which are scheduled to be announced on Tuesday, 6 September 2005. Pre-Closed Period Update Both our Services and Pharmaceuticals Divisions have continued to perform wellbuilding on the good growth achieved in the first half, reflecting the on-goingimprovement in market conditions, and further penetration of new products andservices within the veterinary markets. The development programme for our own branded licensed veterinary productportfolio into North America, Europe and Japan is progressing; we expect to givefurther details in our preliminary announcement in September. The Board expects the results for the full year ended 30 June 2005 to be in linewith management expectations. All areas of our business are performing well and the Group expects to makefurther progress in this new financial year. Enquiries:Ian Page, Chief ExecutiveSimon Evans, Group Finance DirectorDechra Pharmaceuticals PLC Fiona TooleyTel: 01782 771100 Citigate Dewe Rogerson07775 642222 (IP) Tel: 0121 455 837007775 642220 (SE) Mobile: 07785 703523www.dechra.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L